uniprotkb:Q81LN0|intact:EBI-2820887	uniprotkb:P37173|intact:EBI-296151	uniprotkb:GBAA_4584(locus name)|uniprotkb:BAS4252(locus name)|uniprotkb:BA_4584(locus name)|uniprotkb:q81ln0_bacan(shortlabel)|irefindex:GB2j4Snn26HiyL4umac7sD150T41392(rogid)	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:vpR(gene name)	uniprotkb:TGFBR2(gene name)	psi-mi:"MI:0398"(two hybrid pooling approach)	Dyer et al. (2010)	pubmed:20711500|imex:IM-13779	taxid:1392(Bacillus anthracis)	taxid:9606(Human)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(intact)	intact:EBI-2820893|irefindex:CgVZ+i37U4LsK6nwwuDKK2ChG+8(rigid)	author-score:1(free-text)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:E9RCM9(secondary-ac)|uniprotkb:E9RCM8(secondary-ac)|uniprotkb:Q6HT38(secondary-ac)|uniprotkb:Q6KMC5(secondary-ac)|go:"GO:0006508"(proteolysis)|go:"GO:0043086"(negative regulation of catalytic activity)|go:"GO:0004252"(serine-type endopeptidase activity)|go:"GO:0042802"(identical protein binding)|interpro:IPR003137(Protease-associated PA)|interpro:IPR010259(Proteinase inhibitor I9, subtilisin propeptide)|interpro:IPR015500(Peptidase S8, subtilisin-related)|interpro:IPR023828|interpro:IPR022398|interpro:IPR023827|interpro:IPR000209(Peptidase S8 and S53, subtilisin, kexin, sedolisin)|refseq:YP_030500.1|refseq:YP_021229.1|refseq:NP_846805.1|uniprotkb:Q81LN0(identity)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:4932(Baker's yeast)	-	-	-	-	-	-	-
uniprotkb:O35613|intact:EBI-77304	uniprotkb:P37173|intact:EBI-296151	uniprotkb:Daxx(gene name synonym)|uniprotkb:daxx_mouse(shortlabel)|irefindex:qxe2zFFAJmtXHlRAzZkQA1zq7+010090(rogid)	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:Daxx(gene name)	uniprotkb:TGFBR2(gene name)	psi-mi:"MI:0096"(pull down)	Perlman et al. (2001)	pubmed:11483955	taxid:10090(Mouse)	taxid:9606(Human)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(intact)	intact:EBI-296235|irefindex:Hxq6FcL0Un5ZqGVb6guI6ksSCR4(rigid)	intact confidence:0.53(free-text)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q9QWV3(secondary-ac)|uniprotkb:Q9QWT8(secondary-ac)|go:"GO:0006351"(transcription, DNA-dependent)|go:"GO:0031396"(regulation of protein ubiquitination)|go:"GO:0045892"(negative regulation of transcription, DNA-dependent)|go:"GO:0006917"(induction of apoptosis)|go:"GO:0000281"(cytokinesis after mitosis)|go:"GO:0006915"(apoptotic process)|go:"GO:0030521"(androgen receptor signaling pathway)|go:"GO:0008134"(transcription factor binding)|go:"GO:0003714"(transcription corepressor activity)|go:"GO:0003713"(transcription coactivator activity)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0050681"(androgen receptor binding)|go:"GO:0016605"(PML body)|go:"GO:0005730"(nucleolus)|go:"GO:0000792"(heterochromatin)|go:"GO:0005829"(cytosol)|interpro:IPR005012(Daxx protein)|interpro:IPR011989(Armadillo-like helical)|refseq:NP_031855.3|refseq:NP_001186662.1|ipi:IPI01026674|uniprotkb:O35613(identity)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:9534(Green monkey)	-	-	-	-	-	-	-
uniprotkb:P35243|intact:EBI-954661	uniprotkb:P37173|intact:EBI-296151	uniprotkb:Cancer-associated retinopathy protein(gene name synonym)|uniprotkb:RCV1(gene name synonym)|uniprotkb:reco_human(shortlabel)|irefindex:a40aBpj2a3EafaLavE1WuT5wJ1k9606(rogid)	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:RCVRN(gene name)	uniprotkb:TGFBR2(gene name)	psi-mi:"MI:0397"(two hybrid array)	- (2011)	imex:IM-15364|pubmed:21988832	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(intact)	intact:EBI-3912871|irefindex:A2dRKKVceHC5T9S46gtv7LCQ2i8(rigid)	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	go:"GO:0007601"(visual perception)|go:"GO:0008048"(calcium sensitive guanylate cyclase activator activity)|go:"GO:0005509"(calcium ion binding)|ensembl:ENSG00000109047|interpro:IPR001125(Recoverin)|interpro:IPR002048(Calcium-binding EF-hand)|interpro:IPR018249|interpro:IPR018247|interpro:IPR011992(EF-Hand type)|interpro:IPR018248|rcsb pdb:2D8N|refseq:NP_002894.1|ipi:IPI00219720|uniprotkb:P35243(identity)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:4932(Baker's yeast)	-	-	-	-	-	-	-
uniprotkb:P37173|intact:EBI-296151	uniprotkb:Q9HD26|intact:EBI-349832	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:CAL(gene name synonym)|uniprotkb:FIG(gene name synonym)|uniprotkb:PDZ protein interacting specifically with TC10(gene name synonym)|uniprotkb:CFTR-associated ligand(gene name synonym)|uniprotkb:Fused in glioblastoma(gene name synonym)|uniprotkb:gopc_human(shortlabel)|irefindex:nyWXK4V9/xiyzGtAQF1ABYHUrfk9606(rogid)	uniprotkb:TGFBR2(gene name)	uniprotkb:GOPC(gene name)	psi-mi:"MI:0397"(two hybrid array)	- (2011)	imex:IM-15364|pubmed:21988832	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(intact)	intact:EBI-3920800|irefindex:XrdS1UQ9Wbw+4W3DeB3QjjJI7Lk(rigid)	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	uniprotkb:Q969U8(secondary-ac)|uniprotkb:Q59FS4(secondary-ac)|uniprotkb:A6NM30(secondary-ac)|go:"GO:0015031"(protein transport)|go:"GO:0051260"(protein homooligomerization)|go:"GO:0006893"(Golgi to plasma membrane transport)|go:"GO:0006888"(ER to Golgi vesicle-mediated transport)|go:"GO:0043004"(cytoplasmic sequestering of CFTR protein)|go:"GO:0045176"(apical protein localization)|go:"GO:0042980"(cystic fibrosis transmembrane conductance regulator binding)|go:"GO:0030140"(trans-Golgi network transport vesicle)|go:"GO:0045211"(postsynaptic membrane)|go:"GO:0014069"(postsynaptic density)|go:"GO:0005886"(plasma membrane)|go:"GO:0000139"(Golgi membrane)|go:"GO:0030054"(cell junction)|ensembl:ENSG00000047932|interpro:IPR001478(PDZ/DHR/GLGF)|rcsb pdb:2DC2|refseq:NP_065132.1|refseq:NP_001017408.1|ipi:IPI00843890|ipi:IPI00556252|ipi:IPI00186721|uniprotkb:Q9HD26(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:4932(Baker's yeast)	-	-	-	-	-	-	-
uniprotkb:P37173|intact:EBI-296151	uniprotkb:Q99K41|intact:EBI-906561	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:Elastin microfibril interface-located protein 1(gene name synonym)|uniprotkb:emil1_mouse(shortlabel)|irefindex:EI5U0Rs9tAme0JfEwyRWyjbwjrs10090(rogid)	uniprotkb:TGFBR2(gene name)	uniprotkb:Emilin1(gene name)	psi-mi:"MI:0007"(anti tag coimmunoprecipitation)	Zacchigna et al. (2006)	pubmed:16530041|imex:IM-11825	taxid:9606(Human)	taxid:10090(Mouse)	psi-mi:"MI:0914"(association)	psi-mi:"MI:0469"(intact)	intact:EBI-902913|imex:IM-11825-3|irefindex:ys6HXA3QFNkamjT9EvpG9CKBhks(rigid)	-	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	go:"GO:0010811"(positive regulation of cell-substrate adhesion)|go:"GO:0030198"(extracellular matrix organization)|go:"GO:0007155"(cell adhesion)|go:"GO:0042802"(identical protein binding)|go:"GO:0030023"(extracellular matrix constituent conferring elasticity)|go:"GO:0005581"(collagen)|ensembl:ENSMUSG00000029163|interpro:IPR008983(Tumour necrosis factor-like)|interpro:IPR011489(EMI)|interpro:IPR008160(Collagen triple helix repeat)|interpro:IPR001073(Complement C1q protein)|refseq:NP_598679.1|ipi:IPI00115516|uniprotkb:Q99K41(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:-1	Spoke	-	-	-	-	-	-
uniprotkb:P10600|intact:EBI-1033020	uniprotkb:P37173|intact:EBI-296151	uniprotkb:tgfb3_human(shortlabel)|irefindex:pPkY9D2AFZVrKFiwA8B4U6BmLb49606(rogid)	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:TGFB3(gene name)	uniprotkb:TGFBR2(gene name)	psi-mi:"MI:0114"(x-ray crystallography)	Hart et al. (2002)	pubmed:11850637	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0469"(intact)	intact:EBI-1033040|irefindex:ZJa6I3x9QzUt5Bj3wu8zueYHBfs(rigid)	intact confidence:0.51(free-text)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0007435"(salivary gland morphogenesis)|go:"GO:0032570"(response to progesterone stimulus)|go:"GO:0045944"(positive regulation of transcription from RNA polymerase II promoter)|go:"GO:0060391"(positive regulation of SMAD protein import into nucleus)|go:"GO:0050714"(positive regulation of protein secretion)|go:"GO:0010862"(positive regulation of pathway-restricted SMAD protein phosphorylation)|go:"GO:0051491"(positive regulation of filopodium assembly)|go:"GO:0010718"(positive regulation of epithelial to mesenchymal transition)|go:"GO:0045740"(positive regulation of DNA replication)|go:"GO:0032967"(positive regulation of collagen biosynthetic process)|go:"GO:0051781"(positive regulation of cell division)|go:"GO:0030501"(positive regulation of bone mineralization)|go:"GO:0002576"(platelet degranulation)|go:"GO:0030168"(platelet activation)|go:"GO:0060021"(palate development)|go:"GO:0043932"(ossification involved in bone remodeling)|go:"GO:0042476"(odontogenesis)|go:"GO:0043524"(negative regulation of neuron apoptosis)|go:"GO:0010936"(negative regulation of macrophage cytokine production)|go:"GO:0008156"(negative regulation of DNA replication)|go:"GO:0008285"(negative regulation of cell proliferation)|go:"GO:0022601"(menstrual cycle phase)|go:"GO:0030879"(mammary gland development)|go:"GO:0048286"(lung alveolus development)|go:"GO:0006917"(induction of apoptosis)|go:"GO:0001701"(in utero embryonic development)|go:"GO:0060325"(face morphogenesis)|go:"GO:0070483"(detection of hypoxia)|go:"GO:0045216"(cell-cell junction organization)|go:"GO:0016049"(cell growth)|go:"GO:0005114"(type II transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0042802"(identical protein binding)|go:"GO:0008083"(growth factor activity)|go:"GO:0031093"(platelet alpha granule lumen)|go:"GO:0031012"(extracellular matrix)|ensembl:ENSG00000119699|interpro:IPR015618(Transforming growth factor beta 3)|interpro:IPR017948|interpro:IPR015615(Transforming growth factor-beta-related)|interpro:IPR016319(Transforming growth factor-beta)|interpro:IPR001111("Transforming growth factor beta (TGFb), N-terminal")|interpro:IPR001839(Transforming growth factor beta)|rcsb pdb:3EO1|rcsb pdb:2PJY|rcsb pdb:1TGK|rcsb pdb:1TGJ|rcsb pdb:1KTZ|refseq:NP_003230.1|reactome:REACT_604|ipi:IPI00021780|uniprotkb:P10600(identity)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:-1	-	PDBe - Data obtained from the Protein Data Bank Europe	-	-	-	-	-
uniprotkb:P37173|intact:EBI-296151	uniprotkb:Q9UER7|intact:EBI-77321	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:BING2(gene name synonym)|uniprotkb:DAP6(gene name synonym)|uniprotkb:Daxx(gene name synonym)|uniprotkb:Fas death domain-associated protein(gene name synonym)|uniprotkb:ETS1-associated protein 1(gene name synonym)|uniprotkb:daxx_human(shortlabel)|irefindex:gdt0ZYt3ZE61GLZekP8jnWjY1VY9606(rogid)	uniprotkb:TGFBR2(gene name)	uniprotkb:DAXX(gene name)	psi-mi:"MI:0018"(two hybrid)	Perlman et al. (2001)	pubmed:11483955	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(intact)	intact:EBI-296166|irefindex:Qeqb9LuEPdsjt+p9bSPhr4CwuBk(rigid)	intact confidence:0.51(free-text)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	uniprotkb:Q5STK9(secondary-ac)|uniprotkb:Q9BWI3(secondary-ac)|uniprotkb:O15208(secondary-ac)|uniprotkb:O15141(secondary-ac)|uniprotkb:O14747(secondary-ac)|go:"GO:0006351"(transcription, DNA-dependent)|go:"GO:0006915"(apoptotic process)|go:"GO:0030521"(androgen receptor signaling pathway)|go:"GO:0008625"(induction of apoptosis via death domain receptors)|go:"GO:0031396"(regulation of protein ubiquitination)|go:"GO:0045892"(negative regulation of transcription, DNA-dependent)|go:"GO:0044419"(interspecies interaction between organisms)|go:"GO:0007257"(activation of JUN kinase activity)|go:"GO:0031625"(ubiquitin protein ligase binding)|go:"GO:0008134"(transcription factor binding)|go:"GO:0005057"(receptor signaling protein activity)|go:"GO:0047485"(protein N-terminus binding)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0002039"(p53 binding)|go:"GO:0031072"(heat shock protein binding)|go:"GO:0050681"(androgen receptor binding)|go:"GO:0016605"(PML body)|go:"GO:0005730"(nucleolus)|go:"GO:0005829"(cytosol)|go:"GO:0000775"(chromosome, centromeric region)|ensembl:ENSG00000206206|ensembl:ENSG00000206279|ensembl:ENSG00000227046|ensembl:ENSG00000231617|ensembl:ENSG00000204209|interpro:IPR005012(Daxx protein)|interpro:IPR011989(Armadillo-like helical)|rcsb pdb:2KZU|rcsb pdb:2KZS|rcsb pdb:2KQS|refseq:NP_001341.1|refseq:NP_001135441.1|ipi:IPI00220885|ipi:IPI00170867|uniprotkb:Q9UER7(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:4932(Baker's yeast)	-	-	-	-	-	-	-
uniprotkb:Q9UER7|intact:EBI-77321	uniprotkb:P37173|intact:EBI-296151	uniprotkb:BING2(gene name synonym)|uniprotkb:DAP6(gene name synonym)|uniprotkb:Daxx(gene name synonym)|uniprotkb:Fas death domain-associated protein(gene name synonym)|uniprotkb:ETS1-associated protein 1(gene name synonym)|uniprotkb:daxx_human(shortlabel)|irefindex:gdt0ZYt3ZE61GLZekP8jnWjY1VY9606(rogid)	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:DAXX(gene name)	uniprotkb:TGFBR2(gene name)	psi-mi:"MI:0019"(coimmunoprecipitation)	Perlman et al. (2001)	pubmed:11483955	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(intact)	intact:EBI-296246|irefindex:Qeqb9LuEPdsjt+p9bSPhr4CwuBk(rigid)	intact confidence:0.51(free-text)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q5STK9(secondary-ac)|uniprotkb:Q9BWI3(secondary-ac)|uniprotkb:O15208(secondary-ac)|uniprotkb:O15141(secondary-ac)|uniprotkb:O14747(secondary-ac)|go:"GO:0006351"(transcription, DNA-dependent)|go:"GO:0006915"(apoptotic process)|go:"GO:0030521"(androgen receptor signaling pathway)|go:"GO:0008625"(induction of apoptosis via death domain receptors)|go:"GO:0031396"(regulation of protein ubiquitination)|go:"GO:0045892"(negative regulation of transcription, DNA-dependent)|go:"GO:0044419"(interspecies interaction between organisms)|go:"GO:0007257"(activation of JUN kinase activity)|go:"GO:0031625"(ubiquitin protein ligase binding)|go:"GO:0008134"(transcription factor binding)|go:"GO:0005057"(receptor signaling protein activity)|go:"GO:0047485"(protein N-terminus binding)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0002039"(p53 binding)|go:"GO:0031072"(heat shock protein binding)|go:"GO:0050681"(androgen receptor binding)|go:"GO:0016605"(PML body)|go:"GO:0005730"(nucleolus)|go:"GO:0005829"(cytosol)|go:"GO:0000775"(chromosome, centromeric region)|ensembl:ENSG00000206206|ensembl:ENSG00000206279|ensembl:ENSG00000227046|ensembl:ENSG00000231617|ensembl:ENSG00000204209|interpro:IPR005012(Daxx protein)|interpro:IPR011989(Armadillo-like helical)|rcsb pdb:2KZU|rcsb pdb:2KZS|rcsb pdb:2KQS|refseq:NP_001341.1|refseq:NP_001135441.1|ipi:IPI00220885|ipi:IPI00170867|uniprotkb:Q9UER7(identity)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:9606(Human)	-	-	-	-	-	-	-
uniprotkb:P37173|intact:EBI-296151	uniprotkb:P16234|intact:EBI-2861522	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:CD140 antigen-like family member A(gene name synonym)|uniprotkb:CD140a antigen(gene name synonym)|uniprotkb:Alpha-type platelet-derived growth factor receptor(gene name synonym)|uniprotkb:Alpha platelet-derived growth factor receptor(gene name synonym)|uniprotkb:Platelet-derived growth factor receptor 2(gene name synonym)|uniprotkb:RHEPDGFRA(gene name synonym)|uniprotkb:PDGFR2(gene name synonym)|uniprotkb:Platelet-derived growth factor alpha receptor(gene name synonym)|uniprotkb:pgfra_human(shortlabel)|irefindex:EPgwWrufh0xXc4hwzybI4WLehSY9606(rogid)	uniprotkb:TGFBR2(gene name)	uniprotkb:PDGFRA(gene name)	psi-mi:"MI:0397"(two hybrid array)	- (2011)	imex:IM-15364|pubmed:21988832	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(intact)	intact:EBI-3912124|irefindex:DNNFotLHOGWgDoNGvMZcigZoE1s(rigid)	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	uniprotkb:Q6P4H5(secondary-ac)|uniprotkb:E9PBH0(secondary-ac)|uniprotkb:Q9UD28(secondary-ac)|uniprotkb:B2RE69(secondary-ac)|uniprotkb:Q96KZ7(secondary-ac)|go:"GO:2000739"(regulation of mesenchymal stem cell differentiation)|go:"GO:2000249"(regulation of actin cytoskeleton reorganization)|go:"GO:0070527"(platelet aggregation)|go:"GO:0070374"(positive regulation of ERK1 and ERK2 cascade)|go:"GO:0060326"(cell chemotaxis)|go:"GO:0050920"(regulation of chemotaxis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0048557"(embryonic digestive tract morphogenesis)|go:"GO:0048015"(phosphatidylinositol-mediated signaling)|go:"GO:0043552"(positive regulation of phosphatidylinositol 3-kinase activity)|go:"GO:0014068"(positive regulation of phosphatidylinositol 3-kinase cascade)|go:"GO:0010863"(positive regulation of phospholipase C activity)|go:"GO:0010544"(negative regulation of platelet activation)|go:"GO:0007204"(elevation of cytosolic calcium ion concentration)|go:"GO:0061298"(retina vasculature development in camera-type eye)|go:"GO:0046777"(protein autophosphorylation)|go:"GO:0048146"(positive regulation of fibroblast proliferation)|go:"GO:0045740"(positive regulation of DNA replication)|go:"GO:0030335"(positive regulation of cell migration)|go:"GO:0018108"(peptidyl-tyrosine phosphorylation)|go:"GO:0072277"(metanephric glomerular capillary formation)|go:"GO:0001553"(luteinization)|go:"GO:0055003"(cardiac myofibril assembly)|go:"GO:0005021"(vascular endothelial growth factor-activated receptor activity)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0005161"(platelet-derived growth factor receptor binding)|go:"GO:0048407"(platelet-derived growth factor binding)|go:"GO:0005018"(platelet-derived growth factor alpha-receptor activity)|go:"GO:0005524"(ATP binding)|go:"GO:0005634"(nucleus)|go:"GO:0005887"(integral to plasma membrane)|go:"GO:0005737"(cytoplasm)|ensembl:ENSG00000134853|interpro:IPR009134(Vascular endothelial growth factor receptor, VEGFR, N-terminal)|interpro:IPR001824(Receptor tyrosine kinase, class III, conserved site)|interpro:IPR016243(Tyrosine-protein kinase, CSF-1/PDGF receptor)|interpro:IPR020635|interpro:IPR008266(Tyrosine protein kinase, active site)|interpro:IPR001245(Tyrosine protein kinase)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR003598(Immunoglobulin subtype 2)|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR013098(Immunoglobulin I-set)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR007110(Immunoglobulin-like)|rcsb pdb:1GQ5|refseq:NP_006197.1|reactome:REACT_111102|ipi:IPI00336178|ipi:IPI00027721|uniprotkb:P16234(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:4932(Baker's yeast)	-	-	-	-	-	-	-
uniprotkb:P37173|intact:EBI-296151	uniprotkb:P07200|intact:EBI-907660	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:tgfb1_pig(shortlabel)|irefindex:M8X8sxTQ7x3n3aZBp8ZWD+fO/549823(rogid)	uniprotkb:TGFBR2(gene name)	uniprotkb:TGFB1(gene name)	psi-mi:"MI:0007"(anti tag coimmunoprecipitation)	Zacchigna et al. (2006)	pubmed:16530041|imex:IM-11825	taxid:9606(Human)	taxid:9823(Pig)	psi-mi:"MI:0914"(association)	psi-mi:"MI:0469"(intact)	intact:EBI-902913|imex:IM-11825-3|irefindex:5yFtBgm07pfES/qg6JxWEx9e4fk(rigid)	-	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	uniprotkb:P08832(secondary-ac)|go:"GO:0002244"(hemopoietic progenitor cell differentiation)|go:"GO:0019049"(evasion of host defenses by virus)|go:"GO:0007173"(epidermal growth factor receptor signaling pathway)|go:"GO:0002062"(chondrocyte differentiation)|go:"GO:0045216"(cell-cell junction organization)|go:"GO:0016049"(cell growth)|go:"GO:0008219"(cell death)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0007184"(SMAD protein import into nucleus)|go:"GO:0007183"(SMAD protein complex assembly)|go:"GO:0032570"(response to progesterone stimulus)|go:"GO:0032355"(response to estradiol stimulus)|go:"GO:0070723"(response to cholesterol)|go:"GO:0017015"(regulation of transforming growth factor beta receptor signaling pathway)|go:"GO:0042306"(regulation of protein import into nucleus)|go:"GO:0051101"(regulation of DNA binding)|go:"GO:0032801"(receptor catabolic process)|go:"GO:0000060"(protein import into nucleus, translocation)|go:"GO:0006611"(protein export from nucleus)|go:"GO:0045893"(positive regulation of transcription, DNA-dependent)|go:"GO:0050714"(positive regulation of protein secretion)|go:"GO:0051897"(positive regulation of protein kinase B signaling cascade)|go:"GO:0035307"(positive regulation of protein dephosphorylation)|go:"GO:0043552"(positive regulation of phosphatidylinositol 3-kinase activity)|go:"GO:0010800"(positive regulation of peptidyl-threonine phosphorylation)|go:"GO:0033138"(positive regulation of peptidyl-serine phosphorylation)|go:"GO:0010862"(positive regulation of pathway-restricted SMAD protein phosphorylation)|go:"GO:0043406"(positive regulation of MAP kinase activity)|go:"GO:0032740"(positive regulation of interleukin-17 production)|go:"GO:0010763"(positive regulation of fibroblast migration)|go:"GO:0010718"(positive regulation of epithelial to mesenchymal transition)|go:"GO:0032967"(positive regulation of collagen biosynthetic process)|go:"GO:0050921"(positive regulation of chemotaxis)|go:"GO:0008284"(positive regulation of cell proliferation)|go:"GO:0051781"(positive regulation of cell division)|go:"GO:0043536"(positive regulation of blood vessel endothelial cell migration)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0045892"(negative regulation of transcription, DNA-dependent)|go:"GO:0048642"(negative regulation of skeletal muscle tissue development)|go:"GO:0001933"(negative regulation of protein phosphorylation)|go:"GO:0045662"(negative regulation of myoblast differentiation)|go:"GO:0045930"(negative regulation of mitotic cell cycle)|go:"GO:0045599"(negative regulation of fat cell differentiation)|go:"GO:0050680"(negative regulation of epithelial cell proliferation)|go:"GO:0008156"(negative regulation of DNA replication)|go:"GO:0022408"(negative regulation of cell-cell adhesion)|go:"GO:0030308"(negative regulation of cell growth)|go:"GO:0043537"(negative regulation of blood vessel endothelial cell migration)|go:"GO:0031575"(mitotic cell cycle G1/S transition checkpoint)|go:"GO:0048535"(lymph node development)|go:"GO:0007050"(cell cycle arrest)|go:"GO:0006954"(inflammatory response)|go:"GO:0006917"(induction of apoptosis)|go:"GO:0006754"(ATP biosynthetic process)|go:"GO:0005114"(type II transforming growth factor beta receptor binding)|go:"GO:0008083"(growth factor activity)|go:"GO:0005578"(proteinaceous extracellular matrix)|go:"GO:0005634"(nucleus)|go:"GO:0005615"(extracellular space)|go:"GO:0005737"(cytoplasm)|interpro:IPR017948|interpro:IPR003939(Transforming growth factor, beta 1)|interpro:IPR015615(Transforming growth factor-beta-related)|interpro:IPR016319(Transforming growth factor-beta)|interpro:IPR001111("Transforming growth factor beta (TGFb), N-terminal")|interpro:IPR001839(Transforming growth factor beta)|rcsb pdb:3RJR|refseq:NP_999180.1|uniprotkb:P07200(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:-1	Spoke	-	-	-	-	-	-
uniprotkb:P37173|intact:EBI-296151	uniprotkb:P07200|intact:EBI-907660	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:tgfb1_pig(shortlabel)|irefindex:M8X8sxTQ7x3n3aZBp8ZWD+fO/549823(rogid)	uniprotkb:TGFBR2(gene name)	uniprotkb:TGFB1(gene name)	psi-mi:"MI:0007"(anti tag coimmunoprecipitation)	Zacchigna et al. (2006)	pubmed:16530041|imex:IM-11825	taxid:9606(Human)	taxid:9823(Pig)	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0469"(intact)	intact:EBI-902937|imex:IM-11825-4|irefindex:5yFtBgm07pfES/qg6JxWEx9e4fk(rigid)	intact confidence:0.52(free-text)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	uniprotkb:P08832(secondary-ac)|go:"GO:0002244"(hemopoietic progenitor cell differentiation)|go:"GO:0019049"(evasion of host defenses by virus)|go:"GO:0007173"(epidermal growth factor receptor signaling pathway)|go:"GO:0002062"(chondrocyte differentiation)|go:"GO:0045216"(cell-cell junction organization)|go:"GO:0016049"(cell growth)|go:"GO:0008219"(cell death)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0007184"(SMAD protein import into nucleus)|go:"GO:0007183"(SMAD protein complex assembly)|go:"GO:0032570"(response to progesterone stimulus)|go:"GO:0032355"(response to estradiol stimulus)|go:"GO:0070723"(response to cholesterol)|go:"GO:0017015"(regulation of transforming growth factor beta receptor signaling pathway)|go:"GO:0042306"(regulation of protein import into nucleus)|go:"GO:0051101"(regulation of DNA binding)|go:"GO:0032801"(receptor catabolic process)|go:"GO:0000060"(protein import into nucleus, translocation)|go:"GO:0006611"(protein export from nucleus)|go:"GO:0045893"(positive regulation of transcription, DNA-dependent)|go:"GO:0050714"(positive regulation of protein secretion)|go:"GO:0051897"(positive regulation of protein kinase B signaling cascade)|go:"GO:0035307"(positive regulation of protein dephosphorylation)|go:"GO:0043552"(positive regulation of phosphatidylinositol 3-kinase activity)|go:"GO:0010800"(positive regulation of peptidyl-threonine phosphorylation)|go:"GO:0033138"(positive regulation of peptidyl-serine phosphorylation)|go:"GO:0010862"(positive regulation of pathway-restricted SMAD protein phosphorylation)|go:"GO:0043406"(positive regulation of MAP kinase activity)|go:"GO:0032740"(positive regulation of interleukin-17 production)|go:"GO:0010763"(positive regulation of fibroblast migration)|go:"GO:0010718"(positive regulation of epithelial to mesenchymal transition)|go:"GO:0032967"(positive regulation of collagen biosynthetic process)|go:"GO:0050921"(positive regulation of chemotaxis)|go:"GO:0008284"(positive regulation of cell proliferation)|go:"GO:0051781"(positive regulation of cell division)|go:"GO:0043536"(positive regulation of blood vessel endothelial cell migration)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0045892"(negative regulation of transcription, DNA-dependent)|go:"GO:0048642"(negative regulation of skeletal muscle tissue development)|go:"GO:0001933"(negative regulation of protein phosphorylation)|go:"GO:0045662"(negative regulation of myoblast differentiation)|go:"GO:0045930"(negative regulation of mitotic cell cycle)|go:"GO:0045599"(negative regulation of fat cell differentiation)|go:"GO:0050680"(negative regulation of epithelial cell proliferation)|go:"GO:0008156"(negative regulation of DNA replication)|go:"GO:0022408"(negative regulation of cell-cell adhesion)|go:"GO:0030308"(negative regulation of cell growth)|go:"GO:0043537"(negative regulation of blood vessel endothelial cell migration)|go:"GO:0031575"(mitotic cell cycle G1/S transition checkpoint)|go:"GO:0048535"(lymph node development)|go:"GO:0007050"(cell cycle arrest)|go:"GO:0006954"(inflammatory response)|go:"GO:0006917"(induction of apoptosis)|go:"GO:0006754"(ATP biosynthetic process)|go:"GO:0005114"(type II transforming growth factor beta receptor binding)|go:"GO:0008083"(growth factor activity)|go:"GO:0005578"(proteinaceous extracellular matrix)|go:"GO:0005634"(nucleus)|go:"GO:0005615"(extracellular space)|go:"GO:0005737"(cytoplasm)|interpro:IPR017948|interpro:IPR003939(Transforming growth factor, beta 1)|interpro:IPR015615(Transforming growth factor-beta-related)|interpro:IPR016319(Transforming growth factor-beta)|interpro:IPR001111("Transforming growth factor beta (TGFb), N-terminal")|interpro:IPR001839(Transforming growth factor beta)|rcsb pdb:3RJR|refseq:NP_999180.1|uniprotkb:P07200(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:-1	-	-	-	-	-	-	-
uniprotkb:P01137|intact:EBI-779636	uniprotkb:P37173|intact:EBI-296151	uniprotkb:TGFB(gene name synonym)|uniprotkb:tgfb1_human(shortlabel)|irefindex:GUaqNKvv9KyghUkyrflFnZiWPAE9606(rogid)	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:TGFB1(gene name)	uniprotkb:TGFBR2(gene name)	psi-mi:"MI:0030"(cross-linking study)	Pardali et al. (2011)	pubmed:20856203|imex:IM-15782	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0407"(direct interaction)	unknown:i2d(i2d)	intact:EBI-3504782|imex:IM-15782-3|irefindex:6aTXUhYFW4OTtOMq/iM1+EG79sk(rigid)	-	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:A8K792(secondary-ac)|uniprotkb:Q9UCG4(secondary-ac)|go:"GO:0008156"(negative regulation of DNA replication)|go:"GO:0022408"(negative regulation of cell-cell adhesion)|go:"GO:0030308"(negative regulation of cell growth)|go:"GO:0043537"(negative regulation of blood vessel endothelial cell migration)|go:"GO:0031575"(mitotic cell cycle G1/S transition checkpoint)|go:"GO:0010742"(macrophage derived foam cell differentiation)|go:"GO:0048535"(lymph node development)|go:"GO:0006917"(induction of apoptosis)|go:"GO:0002244"(hemopoietic progenitor cell differentiation)|go:"GO:0019049"(evasion of host defenses by virus)|go:"GO:0019058"(viral infectious cycle)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0007184"(SMAD protein import into nucleus)|go:"GO:0007183"(SMAD protein complex assembly)|go:"GO:0007435"(salivary gland morphogenesis)|go:"GO:0032570"(response to progesterone stimulus)|go:"GO:0032355"(response to estradiol stimulus)|go:"GO:0070723"(response to cholesterol)|go:"GO:0017015"(regulation of transforming growth factor beta receptor signaling pathway)|go:"GO:0051101"(regulation of DNA binding)|go:"GO:0032801"(receptor catabolic process)|go:"GO:0000060"(protein import into nucleus, translocation)|go:"GO:0006611"(protein export from nucleus)|go:"GO:0045944"(positive regulation of transcription from RNA polymerase II promoter)|go:"GO:0060391"(positive regulation of SMAD protein import into nucleus)|go:"GO:0050714"(positive regulation of protein secretion)|go:"GO:0051897"(positive regulation of protein kinase B signaling cascade)|go:"GO:0035307"(positive regulation of protein dephosphorylation)|go:"GO:0043552"(positive regulation of phosphatidylinositol 3-kinase activity)|go:"GO:0010800"(positive regulation of peptidyl-threonine phosphorylation)|go:"GO:0033138"(positive regulation of peptidyl-serine phosphorylation)|go:"GO:0010862"(positive regulation of pathway-restricted SMAD protein phosphorylation)|go:"GO:0043406"(positive regulation of MAP kinase activity)|go:"GO:0048298"(positive regulation of isotype switching to IgA isotypes)|go:"GO:0032740"(positive regulation of interleukin-17 production)|go:"GO:0010763"(positive regulation of fibroblast migration)|go:"GO:0010718"(positive regulation of epithelial to mesenchymal transition)|go:"GO:0032967"(positive regulation of collagen biosynthetic process)|go:"GO:0050921"(positive regulation of chemotaxis)|go:"GO:0051781"(positive regulation of cell division)|go:"GO:0030501"(positive regulation of bone mineralization)|go:"GO:0043536"(positive regulation of blood vessel endothelial cell migration)|go:"GO:0002576"(platelet degranulation)|go:"GO:0030168"(platelet activation)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0043932"(ossification involved in bone remodeling)|go:"GO:0048642"(negative regulation of skeletal muscle tissue development)|go:"GO:0001933"(negative regulation of protein phosphorylation)|go:"GO:0045662"(negative regulation of myoblast differentiation)|go:"GO:0045930"(negative regulation of mitotic cell cycle)|go:"GO:0010936"(negative regulation of macrophage cytokine production)|go:"GO:0045599"(negative regulation of fat cell differentiation)|go:"GO:0050680"(negative regulation of epithelial cell proliferation)|go:"GO:0007173"(epidermal growth factor receptor signaling pathway)|go:"GO:0002248"(connective tissue replacement involved in inflammatory response wound healing)|go:"GO:0002062"(chondrocyte differentiation)|go:"GO:0045216"(cell-cell junction organization)|go:"GO:0016049"(cell growth)|go:"GO:0007050"(cell cycle arrest)|go:"GO:0006754"(ATP biosynthetic process)|go:"GO:0046732"(active induction of host immune response by virus)|go:"GO:0005114"(type II transforming growth factor beta receptor binding)|go:"GO:0008083"(growth factor activity)|go:"GO:0005578"(proteinaceous extracellular matrix)|go:"GO:0031093"(platelet alpha granule lumen)|go:"GO:0005634"(nucleus)|go:"GO:0005796"(Golgi lumen)|go:"GO:0005615"(extracellular space)|ensembl:ENSG00000105329|interpro:IPR017948|interpro:IPR003939(Transforming growth factor, beta 1)|interpro:IPR015615(Transforming growth factor-beta-related)|interpro:IPR016319(Transforming growth factor-beta)|interpro:IPR001111("Transforming growth factor beta (TGFb), N-terminal")|interpro:IPR001839(Transforming growth factor beta)|rcsb pdb:3KFD|rcsb pdb:1KLD|rcsb pdb:1KLC|rcsb pdb:1KLA|refseq:NP_000651.3|reactome:REACT_111102|reactome:REACT_6167|reactome:REACT_604|ipi:IPI00000075|uniprotkb:P01137(identity)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:9606(Human)	-	Cancer - Interactions investigated in the context of cancer	-	-	-	-	-
uniprotkb:P01137|intact:EBI-779636	uniprotkb:P37173|intact:EBI-296151	uniprotkb:TGFB(gene name synonym)|uniprotkb:tgfb1_human(shortlabel)|irefindex:GUaqNKvv9KyghUkyrflFnZiWPAE9606(rogid)	uniprotkb:Transforming growth factor-beta receptor type II(gene name synonym)|uniprotkb:TGF-beta type II receptor(gene name synonym)|uniprotkb:tgfr2_human(shortlabel)|irefindex:hxcAAra96c/MOyY41mR/8MT0fcI9606(rogid)	uniprotkb:TGFB1(gene name)	uniprotkb:TGFBR2(gene name)	psi-mi:"MI:0030"(cross-linking study)	Pardali et al. (2011)	pubmed:20856203|imex:IM-15782	taxid:9606(Human)	taxid:9606(Human)	psi-mi:"MI:0407"(direct interaction)	unknown:i2d(i2d)	intact:EBI-3504814|imex:IM-15782-8|irefindex:6aTXUhYFW4OTtOMq/iM1+EG79sk(rigid)	-	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	uniprotkb:A8K792(secondary-ac)|uniprotkb:Q9UCG4(secondary-ac)|go:"GO:0008156"(negative regulation of DNA replication)|go:"GO:0022408"(negative regulation of cell-cell adhesion)|go:"GO:0030308"(negative regulation of cell growth)|go:"GO:0043537"(negative regulation of blood vessel endothelial cell migration)|go:"GO:0031575"(mitotic cell cycle G1/S transition checkpoint)|go:"GO:0010742"(macrophage derived foam cell differentiation)|go:"GO:0048535"(lymph node development)|go:"GO:0006917"(induction of apoptosis)|go:"GO:0002244"(hemopoietic progenitor cell differentiation)|go:"GO:0019049"(evasion of host defenses by virus)|go:"GO:0019058"(viral infectious cycle)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0007184"(SMAD protein import into nucleus)|go:"GO:0007183"(SMAD protein complex assembly)|go:"GO:0007435"(salivary gland morphogenesis)|go:"GO:0032570"(response to progesterone stimulus)|go:"GO:0032355"(response to estradiol stimulus)|go:"GO:0070723"(response to cholesterol)|go:"GO:0017015"(regulation of transforming growth factor beta receptor signaling pathway)|go:"GO:0051101"(regulation of DNA binding)|go:"GO:0032801"(receptor catabolic process)|go:"GO:0000060"(protein import into nucleus, translocation)|go:"GO:0006611"(protein export from nucleus)|go:"GO:0045944"(positive regulation of transcription from RNA polymerase II promoter)|go:"GO:0060391"(positive regulation of SMAD protein import into nucleus)|go:"GO:0050714"(positive regulation of protein secretion)|go:"GO:0051897"(positive regulation of protein kinase B signaling cascade)|go:"GO:0035307"(positive regulation of protein dephosphorylation)|go:"GO:0043552"(positive regulation of phosphatidylinositol 3-kinase activity)|go:"GO:0010800"(positive regulation of peptidyl-threonine phosphorylation)|go:"GO:0033138"(positive regulation of peptidyl-serine phosphorylation)|go:"GO:0010862"(positive regulation of pathway-restricted SMAD protein phosphorylation)|go:"GO:0043406"(positive regulation of MAP kinase activity)|go:"GO:0048298"(positive regulation of isotype switching to IgA isotypes)|go:"GO:0032740"(positive regulation of interleukin-17 production)|go:"GO:0010763"(positive regulation of fibroblast migration)|go:"GO:0010718"(positive regulation of epithelial to mesenchymal transition)|go:"GO:0032967"(positive regulation of collagen biosynthetic process)|go:"GO:0050921"(positive regulation of chemotaxis)|go:"GO:0051781"(positive regulation of cell division)|go:"GO:0030501"(positive regulation of bone mineralization)|go:"GO:0043536"(positive regulation of blood vessel endothelial cell migration)|go:"GO:0002576"(platelet degranulation)|go:"GO:0030168"(platelet activation)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0043932"(ossification involved in bone remodeling)|go:"GO:0048642"(negative regulation of skeletal muscle tissue development)|go:"GO:0001933"(negative regulation of protein phosphorylation)|go:"GO:0045662"(negative regulation of myoblast differentiation)|go:"GO:0045930"(negative regulation of mitotic cell cycle)|go:"GO:0010936"(negative regulation of macrophage cytokine production)|go:"GO:0045599"(negative regulation of fat cell differentiation)|go:"GO:0050680"(negative regulation of epithelial cell proliferation)|go:"GO:0007173"(epidermal growth factor receptor signaling pathway)|go:"GO:0002248"(connective tissue replacement involved in inflammatory response wound healing)|go:"GO:0002062"(chondrocyte differentiation)|go:"GO:0045216"(cell-cell junction organization)|go:"GO:0016049"(cell growth)|go:"GO:0007050"(cell cycle arrest)|go:"GO:0006754"(ATP biosynthetic process)|go:"GO:0046732"(active induction of host immune response by virus)|go:"GO:0005114"(type II transforming growth factor beta receptor binding)|go:"GO:0008083"(growth factor activity)|go:"GO:0005578"(proteinaceous extracellular matrix)|go:"GO:0031093"(platelet alpha granule lumen)|go:"GO:0005634"(nucleus)|go:"GO:0005796"(Golgi lumen)|go:"GO:0005615"(extracellular space)|ensembl:ENSG00000105329|interpro:IPR017948|interpro:IPR003939(Transforming growth factor, beta 1)|interpro:IPR015615(Transforming growth factor-beta-related)|interpro:IPR016319(Transforming growth factor-beta)|interpro:IPR001111("Transforming growth factor beta (TGFb), N-terminal")|interpro:IPR001839(Transforming growth factor beta)|rcsb pdb:3KFD|rcsb pdb:1KLD|rcsb pdb:1KLC|rcsb pdb:1KLA|refseq:NP_000651.3|reactome:REACT_111102|reactome:REACT_6167|reactome:REACT_604|ipi:IPI00000075|uniprotkb:P01137(identity)	uniprotkb:Q99474(secondary-ac)|uniprotkb:Q6DKT6(secondary-ac)|uniprotkb:Q15580(secondary-ac)|uniprotkb:B4DTV5(secondary-ac)|go:"GO:0001570"(vasculogenesis)|go:"GO:0007179"(transforming growth factor beta receptor signaling pathway)|go:"GO:0042493"(response to drug)|go:"GO:0070723"(response to cholesterol)|go:"GO:0040008"(regulation of growth)|go:"GO:0002651"(positive regulation of tolerance induction to self antigen)|go:"GO:0002666"(positive regulation of T cell tolerance induction)|go:"GO:2000379"(positive regulation of reactive oxygen species metabolic process)|go:"GO:0051138"(positive regulation of NK T cell differentiation)|go:"GO:0002053"(positive regulation of mesenchymal cell proliferation)|go:"GO:0002663"(positive regulation of B cell tolerance induction)|go:"GO:0018107"(peptidyl-threonine phosphorylation)|go:"GO:0018105"(peptidyl-serine phosphorylation)|go:"GO:0001569"(patterning of blood vessels)|go:"GO:0060389"(pathway-restricted SMAD protein phosphorylation)|go:"GO:0060021"(palate development)|go:"GO:0043011"(myeloid dendritic cell differentiation)|go:"GO:0007507"(heart development)|go:"GO:0035162"(embryonic hemopoiesis)|go:"GO:0048701"(embryonic cranial skeleton morphogenesis)|go:"GO:0007420"(brain development)|go:"GO:0006915"(apoptotic process)|go:"GO:0032147"(activation of protein kinase activity)|go:"GO:0034714"(type III transforming growth factor beta receptor binding)|go:"GO:0034713"(type I transforming growth factor beta receptor binding)|go:"GO:0005026"(transforming growth factor beta receptor activity, type II)|go:"GO:0050431"(transforming growth factor beta binding)|go:"GO:0046332"(SMAD binding)|go:"GO:0004702"(receptor signaling protein serine/threonine kinase activity)|go:"GO:0005515"(protein binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0005539"(glycosaminoglycan binding)|go:"GO:0005524"(ATP binding)|go:"GO:0070022"(transforming growth factor beta receptor complex)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0005901"(caveola)|ensembl:ENSG00000163513|interpro:IPR015013(Transforming growth factor beta receptor 2 ectodomain)|interpro:IPR017194(Transforming growth factor-beta receptor, type II)|interpro:IPR008271(Serine/threonine protein kinase, active site)|interpro:IPR017442(Serine/threonine protein kinase-related)|interpro:IPR017441(Protein kinase ATP binding, conserved site)|interpro:IPR000719(Protein kinase, core)|interpro:IPR011009(Protein kinase-like)|interpro:IPR000333(Activin type II receptor)|rcsb pdb:3KFD|rcsb pdb:2PJY|rcsb pdb:1PLO|rcsb pdb:1M9Z|rcsb pdb:1KTZ|refseq:NP_003233.4|refseq:NP_001020018.1|reactome:REACT_111102|ipi:IPI00164934|ipi:IPI00020431|uniprotkb:P37173(identity)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	taxid:9606(Human)	-	Cancer - Interactions investigated in the context of cancer	-	-	-	-	-